Association between maternal occupational exposure to organic solvents and congenital heart defects, National Birth Defects Prevention Study, 1997-2002

Occupational and Environmental Medicine

Volumn 69, Issue 9, 2012, Pages 628-635

  Gilboa, Suzanne M ^a   Desrosiers, Tania A ^b   Lawson, Christina ^c   Lupo, Philip J ^d   Riehle Colarusso, Tiffany J ^a   Stewart, Patricia A ^e   Van Wijngaarden, Edwin ^f   Waters, Martha A ^c   Correa, Adolfo ^a,g  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b IL   (United States)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^e Stewart Exposure Assessments LLC   (United States)

^f UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^g UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORGANIC SOLVENT;

AORTA STENOSIS; ARTICLE; CONGENITAL HEART MALFORMATION; CONSENSUS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; FIRST TRIMESTER PREGNANCY; GREAT VESSELS TRANSPOSITION; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INFANT; MEDICAL LITERATURE; MOTHER; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROGENY; PULMONARY VALVE STENOSIS;

ADOLESCENT; ADULT; AORTIC VALVE STENOSIS; CASE-CONTROL STUDIES; FEMALE; HEART DEFECTS, CONGENITAL; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; HYDROCARBONS; HYDROCARBONS, CHLORINATED; INFANT, NEWBORN; LOGISTIC MODELS; MATERNAL EXPOSURE; OCCUPATIONAL EXPOSURE; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS; PULMONARY VALVE STENOSIS; RISK FACTORS; SOLVENTS; TRANSPOSITION OF GREAT VESSELS; VENTRICULAR OUTFLOW OBSTRUCTION; YOUNG ADULT;

EID: 84865516777     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oemed-2011-100536     Document Type: Article

References (41)

1. National Institute for Occupational Safety and Health (NIOSH). Workplace Safety & Health Topics: Organic Solvents. http://www.cdc.gov/niosh/topics/ organsolv/ (accessed 25 Oct 2011).
2. Bruckner JV, Anand SS, Warren DA. Toxic effects of solvents and vapors. In: Klaassen CD, ed. Casarett and Doull's Toxicology: The Basic Science of Poisons. 7th edn. New York: McGraw-Hill, 2008:1309.
3. Reller MD, Strickland MJ, Riehle-Colarusso T, et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 2008;153:807-13.
4. Botto LD, Correa A, Erickson JD. Racial and temporal variations in the prevalence of heart defects. Pediatrics 2001;107:E32.
5. Centers for Disease Control and Prevention (CDC). Economic costs of birth defects and cerebral palsydUnited States, 1992. MMWR Morb Mortal Wkly Rep 1995;44:694-9.
6. Gilboa SM, Salemi JL, Nembhard WN, et al. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation 2010;122:2254-63.
7. Boneva RS, Botto LD, Moore CA, et al. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation 2001;103:2376-81. (Pubitemid 32448803)
8. Tikkanen J, Heinonen OP. Cardiovascular malformations and organic solvent exposure during pregnancy in Finland. Am J Ind Med 1988;14:1-8.
9. Tikkanen J, Heinonen OP. Risk factors for ventricular septal defect in Finland. Public Health 1991;105:99-112.
10. Tikkanen J, Heinonen OP. Risk factors for conal malformations of the heart. Eur J Epidemiol 1992;8:48-57.
11. Ferencz C, Correa-Villasenor A, Loffredo CA, et al. Genetic and environmental risk factors of major congenital malformations: the Baltimore Washington Infant Study: 1981-1989. Perspectives in Pediatric Cardiology. Vol. 5. Armonk: Futura Publishing Company, Inc., 1997.
12. Ferencz C, Loffredo CA, Rubin JD, et al. Epidemiology of congenital heart disease: The Baltimore-Washington Infant Study 1981-1989. Perspectives in Pediatric Cardiology. Vol. 4. Mount Kisco: Futura Publishing Company, Inc., 1993.
13. Loffredo CA. Epidemiology of cardiovascular malformations: prevalence and risk factors. Am J Med Genet 2000;97:319-25. (Pubitemid 32463497)
14. Correa-Villasenor A, Ferencz C, Boughman JA, et al. Total anomalous pulmonary venous return: familial and environmental factors. The Baltimore-Washington Infant Study Group. Teratology 1991;44:415-28.
15. Correa-Villasenor A, Ferencz C, Neill CA, et al. Ebstein's malformation of the tricuspid valve: genetic and environmental factors. The Baltimore-Washington Infant Study Group. Teratology 1994;50:137-47. (Pubitemid 24289115)
16. Cordier S, Ha MC, Ayme S, et al. Maternal occupational exposure and congenital malformations. Scand J Work Environ Health 1992;18:11-17.
17. Garlantezec R, Monfort C, Rouget F, et al. Maternal occupational exposure to solvents and congenital malformations: a prospective study in the general population. Occup Environ Med 2009;66:456-63.
18. Botto LD, Lin AE, Riehle-Colarusso T, et al. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol 2007;79:714-27. (Pubitemid 47584196)
19. Rasmussen SA, Olney RS, Holmes LB, et al. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 2003;67:193-201. (Pubitemid 37238061)
20. Yoon PW, Rasmussen SA, Lynberg MC, et al. The National Birth Defects Prevention Study. Public Health Rep 2001;116(Suppl 1):32-40. (Pubitemid 32822091)
21. Rasmussen SA, Riehle-Colarusso T, Shapira SK, et al. Letter to the editor: ventricular septal defects and the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 2011;91:66.
22. United States Department of Labor, Bureau of Labor and Statistics. Standard Occupational Classification, 2001. http://www.bls.gov/soc/soc-majo.htm (accessed 25 Oct 2011).
23. United States Department of Labor, Bureau of Labor and Statistics. North American Industry Classification System, 2009. http://www.bls.gov/bls/naics.htm (accessed 25 Oct 2011).
24. Rocheleau CM, Lawson CC, Waters MA, et al. Inter-rater reliability of assessed prenatal maternal occupational exposures to solvents, polycyclic aromatic hydrocarbons, and heavy metals. J Occup Environ Hyg 2011;8:718-28.
25. Correa A, Min YI, Stewart PA, et al. Inter-rater agreement of assessed prenatal maternal occupational exposures to lead. Birth Defects Res A Clin Mol Teratol 2006;76:811-24.
26. Jackson LW, Correa-Villasenor A, Lees PS, et al. Parental lead exposure and total anomalous pulmonary venous return. Birth Defects Res A Clin Mol Teratol 2004;70:185-93. (Pubitemid 38581384)
27. Bakke B, Stewart PA, Waters MA. Uses of and exposure to trichloroethylene in U.S. industry: a systematic literature review. J Occup Environ Hyg 2007;4:375-90.
28. Gold LS, De Roos AJ, Waters M, et al. Systematic literature review of uses and levels of occupational exposure to tetrachloroethylene. J Occup Environ Hyg 2008;5:807-39.
29. Hein MJ, Waters MA, van Wijngaarden E, et al. Issues when modeling benzene, toluene, and xylene exposures using a literature database. J Occup Environ Hyg 2008;5:36-47.
30. van Wijngaarden E, Stewart PA. Critical literature review of determinants and levels of occupational benzene exposure for United States community-based casecontrol studies. Appl Occup Environ Hyg 2003;18:678-93. (Pubitemid 37075655)
31. Sadler TW. Langman's Medical Embyrology. 10th edn. Philadelphia: Lippincott Williams & Wilkins, 2006.
32. Alverson CJ, Strickland MJ, Gilboa SM, et al. Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study. Pediatrics 2011;127:e647-53.
33. Malik S, Cleves MA, Honein MA, et al. Maternal smoking and congenital heart defects. Pediatrics 2008;121:e810-16.
34. Botto LD, Mulinare J, Erickson JD. Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Evidence and gaps. Am J Med Genet A 2003;121A:95-101. (Pubitemid 37075511)
35. Hansen JM. Oxidative stress as a mechanism of teratogenesis. Birth Defects Res C Embryo Today 2006;78:293-307. (Pubitemid 46365293)
36. Johnson PD, Dawson BV, Goldberg SJ. Cardiac teratogenicity of trichloroethylene metabolites. J Am Coll Cardiol 1998;32:540-5. (Pubitemid 28397742)
37. Drake VJ, Koprowski SL, Hu N, et al. Cardiogenic effects of trichloroethylene and trichloroacetic acid following exposure during heart specification of avian development. Toxicol Sci 2006;94:153-62. (Pubitemid 44542338)
38. Blair A, Stewart P, Lubin JH, et al. Methodological issues regarding confounding and exposure misclassification in epidemiological studies of occupational exposures. Am J Ind Med 2007;50:199-207. (Pubitemid 46363811)
39. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Trichloroethylene (Update). Atlanta, GA: U.S. Public Health Service, 1997.
40. Cogswell ME, Bitsko RH, Anderka M, et al; National Birth Defects Prevention Study. Control selection and participation in an ongoing, population-based, case-control study of birth defects, the National Birth Defects Prevention Study. Am J Epidemiol 2009;170:975-85.
41. Oyen N, Poulsen G, Boyd HA, et al. National time trends in congenital heart defects, Denmark, 1977-2005. Am Heart J 2009;157:467-73.